PTC Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
28.05.24
/
50%
€33.60
Target price
28.05.25
€29.42
Performance (%)
-6.55%
Price
29.08.24
€31.60
Summary
This prediction is currently active. With a performance of -6.55%, the SELL prediction by The_Goldman_Sachs_Gr is trending in the right direction. This prediction currently runs until 28.05.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 5.333% | 5.333% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $32.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.00
21.05.24
21.05.24
€29.48
21.05.25
21.05.25
-9.71%
29.08.24
29.08.24
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.80
18.09.23
18.09.23
€20.61
18.09.24
18.09.24
37.72%
29.08.24
29.08.24